This page contains brief details about the drug , it's indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.
Background and Date of Approval
Safinamide received its initial approval for medical by FDA (Food and Drug Administration) approved Safinamide on March 21, 2017.
Mechanism of Action of undefined
Safinamide works by increasing levels of dopamine in the brain, helping to manage symptoms like tremors, stiffness, and slowness of movement associated with Parkinson's disease.
Uses of undefined
Safinamide is primarily used as an adjunct medication for Parkinson's disease management. It helps control symptoms like tremors and movement difficulties by increasing dopamine levels in the brain.
undefined Drug administaration and Dosage available
Safinamide is administered orally, meaning you take it by mouth and is available as 50 and 100mg tablet. The recommended dosage may be adjusted by a healthcare professional as needed.
Warnings, Precautions and Side Effects of undefined
Warnings
Safinamide may cause an increase in blood pressure. Some individuals may experience hallucinations, confusion, or changes in mood or behavior while taking this medication.
Precautions
Regular monitoring of blood pressure is recommended, especially at the start of Safinamide or with any dosage adjustments. Promptly inform your healthcare provider if any unusual mental health changes occur.
Side Effects
Common side effects of Safinamide may include symptoms like nausea, insomnia, dizziness, headache, and uncontrolled movements. Serious side effects, although less common includes allergic reactions, which might present as rashes, itching, swelling, or even difficulties in breathing. Additionally, it may rarely lead to hallucinations or psychiatric symptoms, serotonin syndrome, or alterations in liver function.
Word Of Advice
Inform your doctor about your medications, supplements, or herbal products to avoid potential interactions. Caution is advised when using Safinamide alongside other medications that also raise serotonin levels, as it could lead to serotonin syndrome. Watch for symptoms like confusion, hallucinations, rapid heart rate, and high blood pressure. Regular blood pressure monitoring is recommended, especially at the start of treatment or with any dosage adjustments. Inform your doctor if you notice any unusual changes in your mental health.
Frequently Asked Question
References
- U.S FDA (Food and Drug Safety Administration), [ Last Revised 21st March 2017], [Accessed on 29th Dec 2023], https://www.fda.gov/news-events/press-announcements/fda-approves-drug-treat-parkinsons-disease
- Baker DE, Kim AP. Formulary Drug Review: Safinamide. Hosp Pharm.[Published on 2017 September] [Accessed on 29th Dec 2023]
Disclaimer
The drug information on this page is not a substitute for medical advice. It is meant for educational purposes only. For further details, consult your doctor about your medical condition to know if you can receive this treatment.